CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • United States
    Entity • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Trade Second Sight Medical Products, - EYES CFD

    1.30
    3.17%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.14
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		-0.025457%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		0.003235%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 20%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 1.26
    Open* 1.3
    1-Year Change* -36.27%
    Day's Range* 1.29 - 1.33
    52 wk Range 1.14-4.24
    Average Volume (10 days) N/A
    Average Volume (3 months) 5.80M
    Market Cap 75.27M
    P/E Ratio -100.00K
    Shares Outstanding 39.41M
    Revenue N/A
    EPS -0.23
    Dividend (Yield %) N/A
    Beta 2.54
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 30, 2022 1.30 -0.01 -0.76% 1.31 1.33 1.29
    Nov 29, 2022 1.26 -0.07 -5.26% 1.33 1.35 1.26
    Nov 28, 2022 1.32 -0.02 -1.49% 1.34 1.40 1.31
    Nov 25, 2022 1.35 0.02 1.50% 1.33 1.39 1.30
    Nov 23, 2022 1.32 -0.02 -1.49% 1.34 1.36 1.25
    Nov 22, 2022 1.33 0.07 5.56% 1.26 1.39 1.24
    Nov 21, 2022 1.33 0.00 0.00% 1.33 1.37 1.30
    Nov 18, 2022 1.34 -0.12 -8.22% 1.46 1.47 1.29
    Nov 17, 2022 1.46 0.01 0.69% 1.45 1.48 1.44
    Nov 16, 2022 1.46 -0.09 -5.81% 1.55 1.55 1.43
    Nov 15, 2022 1.54 -0.04 -2.53% 1.58 1.59 1.52
    Nov 14, 2022 1.55 -0.06 -3.73% 1.61 1.64 1.51
    Nov 11, 2022 1.63 0.03 1.87% 1.60 1.64 1.52
    Nov 10, 2022 1.59 -0.04 -2.45% 1.63 1.67 1.57
    Nov 9, 2022 1.59 -0.09 -5.36% 1.68 1.69 1.51
    Nov 8, 2022 1.63 -0.07 -4.12% 1.70 1.72 1.62
    Nov 7, 2022 1.72 -0.02 -1.15% 1.74 1.77 1.69
    Nov 4, 2022 1.74 -0.01 -0.57% 1.75 1.80 1.74
    Nov 3, 2022 1.79 -0.02 -1.10% 1.81 1.82 1.79
    Nov 2, 2022 1.79 0.03 1.70% 1.76 1.87 1.76

    Second Sight Medical Products, Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total revenue 0 0 3.379 6.896 7.964
    Revenue 0 0 3.379 6.896 7.964
    Cost of Revenue, Total -0.13 -0.5 2.152 4.888 5.117
    Gross Profit 0.13 0.5 1.227 2.008 2.847
    Total Operating Expense 8.933 14.896 37.333 42.076 36.573
    Selling/General/Admin. Expenses, Total 6.693 8.331 18.681 26.628 23.563
    Research & Development 2.37 4.836 13.143 10.005 7.893
    Unusual Expense (Income) 0 2.229 3.357 0.555
    Operating Income -8.933 -14.896 -33.954 -35.18 -28.609
    Interest Income (Expense), Net Non-Operating 0.012 0.016 0.362 0.086 0.093
    Other, Net 0
    Net Income Before Taxes -8.921 -14.88 -33.592 -35.094 -28.516
    Net Income After Taxes -8.921 -14.88 -33.592 -35.094 -28.516
    Net Income Before Extra. Items -8.921 -14.88 -33.592 -35.094 -28.516
    Net Income -8.921 -14.88 -33.592 -35.094 -28.516
    Income Available to Common Excl. Extra. Items -8.921 -14.88 -33.592 -35.094 -28.516
    Income Available to Common Incl. Extra. Items -8.921 -14.88 -33.592 -35.094 -28.516
    Diluted Net Income -8.921 -14.88 -33.592 -35.094 -28.516
    Diluted Weighted Average Shares 32.817 20.575 14.708 8.29725 6.769
    Diluted EPS Excluding Extraordinary Items -0.27184 -0.72321 -2.28393 -4.22959 -4.21273
    Dividends per Share - Common Stock Primary Issue 0
    Diluted Normalized EPS -0.27184 -0.58085 -2.05568 -4.1627 -4.21273
    Total Extraordinary Items 0
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total revenue 0 0 0 0 0
    Revenue 0 0 0 0 0
    Total Operating Expense 2.216 1.291 2.503 2.296 2.843
    Selling/General/Admin. Expenses, Total 1.571 0.777 1.806 1.601 2.509
    Research & Development 0.645 0.644 0.697 0.695 0.334
    Operating Income -2.216 -1.291 -2.503 -2.296 -2.843
    Interest Income (Expense), Net Non-Operating 0.004 0.008 0.002 0.002 0
    Net Income Before Taxes -2.212 -1.283 -2.501 -2.294 -2.843
    Net Income After Taxes -2.212 -1.283 -2.501 -2.294 -2.843
    Net Income Before Extra. Items -2.212 -1.283 -2.501 -2.294 -2.843
    Net Income -2.212 -1.283 -2.501 -2.294 -2.843
    Income Available to Common Excl. Extra. Items -2.212 -1.283 -2.501 -2.294 -2.843
    Income Available to Common Incl. Extra. Items -2.212 -1.283 -2.501 -2.294 -2.843
    Diluted Net Income -2.212 -1.283 -2.501 -2.294 -2.843
    Diluted Weighted Average Shares 39.409 39.48 39.409 28.667 23.537
    Diluted EPS Excluding Extraordinary Items -0.05613 -0.0325 -0.06346 -0.08002 -0.12079
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.05613 -0.0325 -0.06346 -0.08002 -0.12079
    Cost of Revenue, Total 0 -0.13 0 0
    Gross Profit 0 0.13 0 0
    Unusual Expense (Income) 0 0 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 70.507 4.269 13.11 9.62 13.165
    Cash and Short Term Investments 69.593 3.177 11.327 4.471 7.839
    Cash 0.604
    Cash & Equivalents 69.593 3.177 11.327 4.471 7.235
    Total Receivables, Net 0.455 0.504 1.831
    Accounts Receivable - Trade, Net 0.455 0.504 1.831
    Total Inventory 0 1.029 3.25 2.7
    Prepaid Expenses 0.914 1.092 0.299 1.395 0.795
    Total Assets 70.879 4.46 16.599 10.682 14.497
    Property/Plant/Equipment, Total - Net 0.345 0.174 3.464 1.025 1.299
    Property/Plant/Equipment, Total - Gross 0.894 0.653 7.12 4.282 4.123
    Accumulated Depreciation, Total -0.549 -0.479 -3.656 -3.257 -2.824
    Long Term Investments 0.027 0.017 0.025 0.037 0.033
    Total Current Liabilities 2.462 5.132 6.959 7.598 6.615
    Accounts Payable 0.519 0.486 1.093 1.305 0.752
    Accrued Expenses 1.943 2.111 5.531 6.126 5.815
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0.335 0.335 0.167 0.048
    Total Liabilities 2.514 5.132 9.324 7.598 6.615
    Total Long Term Debt 0 0 0 0 0
    Total Equity 68.365 -0.672 7.275 3.084 7.882
    Common Stock 347.94 270.126 264.008 229.019 202.156
    Additional Paid-In Capital 49.389 49.314 48.613 44.111 40.675
    Retained Earnings (Accumulated Deficit) -328.585 -319.664 -304.784 -269.471 -234.377
    Other Equity, Total -0.379 -0.448 -0.562 -0.575 -0.572
    Total Liabilities & Shareholders’ Equity 70.879 4.46 16.599 10.682 14.497
    Total Common Shares Outstanding 39.409 23.214 15.643 9.542 7.20375
    Other Liabilities, Total 0.052 0 2.365
    Current Port. of LT Debt/Capital Leases 0 2.2
    Preferred Stock - Non Redeemable, Net 0
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 60.217 70.507 73.221 75.438 27.621
    Cash and Short Term Investments 59.599 69.593 72.028 73.845 26.862
    Cash & Equivalents 59.599 69.593 72.028 73.845 26.862
    Prepaid Expenses 0.418 0.914 1.193 1.593 0.759
    Total Assets 68.538 70.879 73.63 75.916 28.145
    Property/Plant/Equipment, Total - Net 0.303 0.345 0.387 0.446 0.505
    Property/Plant/Equipment, Total - Gross 0.868 0.894 0.923 0.964 1.004
    Accumulated Depreciation, Total -0.565 -0.549 -0.536 -0.518 -0.499
    Long Term Investments 8.018 0.027 0.022 0.032 0.019
    Total Current Liabilities 2.385 2.462 3.919 3.661 6.94
    Accounts Payable 0.744 0.519 0.758 0.67 1.607
    Accrued Expenses 1.26 1.943 2.826 2.656 2.798
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 0 0 2.2
    Other Current Liabilities, Total 0.381 0.335 0.335 0.335
    Total Liabilities 2.385 2.514 4.021 3.812 7.139
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 0 0.052 0.102 0.151 0.199
    Total Equity 66.153 68.365 69.609 72.104 21.006
    Common Stock 347.94 347.94 347.94 347.94 294.592
    Additional Paid-In Capital 49.402 49.389 49.371 49.352 49.333
    Retained Earnings (Accumulated Deficit) -330.797 -328.585 -327.302 -324.801 -322.507
    Other Equity, Total -0.392 -0.379 -0.4 -0.387 -0.412
    Total Liabilities & Shareholders’ Equity 68.538 70.879 73.63 75.916 28.145
    Total Common Shares Outstanding 39.409 39.409 39.409 39.409 27.908
    Preferred Stock - Non Redeemable, Net 0 0 0
    Total Receivables, Net 0.2
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line -8.921 -14.88 -33.592 -35.094 -28.516
    Cash From Operating Activities -9.188 -16.822 -27.629 -29.81 -23.947
    Cash From Operating Activities 0.07 0.164 0.397 0.435 0.457
    Non-Cash Items 0.084 1.638 5.529 4.424 0.798
    Changes in Working Capital -0.421 -3.744 0.037 0.425 3.314
    Cash From Investing Activities -0.014 0.068 -0.493 -0.163 -0.265
    Capital Expenditures -0.014 -0.33 -0.493 -0.163 -0.265
    Cash From Financing Activities 75.616 8.598 34.989 26.601 21.168
    Issuance (Retirement) of Stock, Net 77.814 6.398 34.989 26.601 21.168
    Foreign Exchange Effects 0.002 0.006 -0.011 0.004 0.008
    Net Change in Cash 66.416 -8.15 6.856 -3.368 -3.036
    Other Investing Cash Flow Items, Total 0 0.398
    Issuance (Retirement) of Debt, Net -2.2 2.2
    Cash Interest Paid 0.135
    Financing Cash Flow Items 0.002
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Net income/Starting Line -2.212 -8.921 -7.638 -5.137 -2.843
    Cash From Operating Activities -1.975 -9.188 -6.763 -4.963 -0.778
    Cash From Operating Activities 0.016 0.07 0.057 0.039 0.02
    Non-Cash Items 0.019 0.084 0.068 0.051 0.035
    Changes in Working Capital 0.202 -0.421 0.75 0.084 2.01
    Cash From Financing Activities 0 75.616 75.614 75.614 24.466
    Issuance (Retirement) of Stock, Net 0 77.814 77.814 77.814 24.466
    Foreign Exchange Effects -0.001 0.002 0 0.017 -0.003
    Net Change in Cash -9.994 66.416 68.851 70.668 23.685
    Cash From Investing Activities -8.018 -0.014 0 0
    Capital Expenditures -0.018 -0.014 0 0
    Issuance (Retirement) of Debt, Net -2.2 -2.2 -2.2
    Other Investing Cash Flow Items, Total -8 0 0
    Cash Interest Paid 0.135
    Financing Cash Flow Items 0.002

    Start a global, multi-asset portfolio with an award-winning platform

    Desktop

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Profit/Loss

    Second Sight Medical Products, Company profile

    Second Sight Medical Products, Inc.
    Industry: Medical Devices & Implants

    Income Statement

    • Annual
    • Quarterly

    News

    Benjamin Franklin’s face on a $100 bill

    USD forecast: DXY slides in risk-off market sentiment

    The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.

    16:10, 24 May 2023
    Oil wells pictured in an oil field, silhouetted against clouds

    Oil price forecast: Will WTI and Brent regain momentum in 2023?

    Discover the drivers behind Brent and WTI volatility and get insights from analyst predictions.

    11:38, 22 May 2023
    businessman using a mobile phone to check stock market data

    Weekly Roundup: Tech stocks lead the way

    US stocks push higher as risk appetite surges despite the uncertainty

    13:39, 19 May 2023
    Japanese yen currency

    USD/JPY continues to build higher towards 138

    USD/JPY advances towards the top of its ascending triangle as the US dollar moves higher

    11:50, 17 May 2023
    Gold bars on a black background with a diagram

    Gold price predictions for next 5 years: Will gold continue rising?

    The yellow metal reached near record-highs, yet will it maintain the momentum and for how long?

    07:50, 17 May 2023
    Close-up of a $20 banknote and gold bullion

    Gold price forecast: Will gold surpass record highs?

    The US debt ceiling concerns and the banking crisis have been favourable for gold, yet is there more upside potential?

    12:52, 16 May 2023

    Top AI stocks: What companies are leading the AI revolution?

    Unravel key AI market leaders and their latest products, key AI industry trends and forecasts.

    14:55, 15 May 2023

    People also watch

    US100

    14,347.30 Price
    +0.160% 1D Chg, %
    Long position overnight fee -0.0255%
    Short position overnight fee 0.0032%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    Gold

    1,945.20 Price
    -0.120% 1D Chg, %
    Long position overnight fee -0.0184%
    Short position overnight fee 0.0102%
    Overnight fee time 21:00 (UTC)
    Spread 0.30

    Oil - Crude

    73.22 Price
    +0.410% 1D Chg, %
    Long position overnight fee -0.0146%
    Short position overnight fee -0.0073%
    Overnight fee time 21:00 (UTC)
    Spread 0.03

    BTC/USD

    27,803.15 Price
    +0.710% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 60.00

    Still looking for a broker you can trust?

    Join the 530.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading